| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |